Seattle Clinical Research Center Recognizes FDA Approval of New Non-Hormonal Copper IUD Following Clinical Trial Participation

Seattle, WA – March 4, 2025 – Seattle Clinical Research Center is pleased to recognize the recent FDA approval of a new non-hormonal copper intrauterine device (IUD), now officially approved for up to three years of use. As one of the leading clinical trial sites involved in the pivotal Phase 3 study, Seattle Clinical Research Center contributed valuable research data … Read more

WE'VE MOVED!